Adverse events1,000

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,000

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Nasopharyngitis	Infections and infestations	Omarigliptin 25 mg	123	2,092	167
other	Nasopharyngitis	Infections and infestations	Placebo	145	2,100	195
other	Upper respiratory tract infection	Infections and infestations	Omarigliptin 25 mg	123	2,092	163
other	Upper respiratory tract infection	Infections and infestations	Placebo	120	2,100	150
other	Blood glucose increased	Investigations	Omarigliptin 25 mg	97	2,092	139
other	Blood glucose increased	Investigations	Placebo	139	2,100	199
other	Hypoglycaemia	Metabolism and nutrition disorders	Omarigliptin 25 mg	530	2,092	3,990
other	Hypoglycaemia	Metabolism and nutrition disorders	Placebo	473	2,100	3,688
other	Urinary tract infection	Infections and infestations	Omarigliptin 25 mg	108	2,092	131
other	Urinary tract infection	Infections and infestations	Placebo	98	2,100	141
serious	Agranulocytosis	Blood and lymphatic system disorders	Omarigliptin 25 mg	1	2,092	1
serious	Agranulocytosis	Blood and lymphatic system disorders	Placebo	0	2,100	0
serious	Anaemia	Blood and lymphatic system disorders	Omarigliptin 25 mg	6	2,092	6
serious	Anaemia	Blood and lymphatic system disorders	Placebo	4	2,100	4
serious	Coagulation factor deficiency	Blood and lymphatic system disorders	Omarigliptin 25 mg	1	2,092	1
serious	Coagulation factor deficiency	Blood and lymphatic system disorders	Placebo	0	2,100	0
serious	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Omarigliptin 25 mg	2	2,092	2
serious	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Placebo	0	2,100	0
serious	Haemorrhagic anaemia	Blood and lymphatic system disorders	Omarigliptin 25 mg	0	2,092	0
serious	Haemorrhagic anaemia	Blood and lymphatic system disorders	Placebo	2	2,100	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01703208/events

API reference For AI assistants

Adverse events1,000

Sources 3

Read this list from software.